FUAD KHORSANDIAN – Trademark Portfolio
Entity Type: 01
FUAD KHORSANDIAN holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PHARMA-BIO-MED. The owner is based in SAN DIEGO, CA.
17055 VIA DEL CAMPO
SUITE 200
SAN DIEGO, CA 92127
Showing of trademarks Trademarks
Trademark Classifications
FUAD KHORSANDIAN's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does FUAD KHORSANDIAN have?
FUAD KHORSANDIAN has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does FUAD KHORSANDIAN file in?
FUAD KHORSANDIAN files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.
What are FUAD KHORSANDIAN's most well-known trademarks?
FUAD KHORSANDIAN's registered trademark portfolio includes well-known marks such as PHARMA-BIO-MED. These are among 1 currently registered trademark in the portfolio.
What is FUAD KHORSANDIAN's trademark registration success rate?
FUAD KHORSANDIAN has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.